Literature DB >> 23921739

A step toward functionally characterized prostate cancer molecular subtypes.

Francesca Demichelis1, Gerhardt Attard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23921739     DOI： 10.1038/nm.3285

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  13 in total

1.  An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression.

Authors:  Jindan Yu; Jianjun Yu; Ram-Shankar Mani; Qi Cao; Chad J Brenner; Xuhong Cao; Xiaoju Wang; Longtao Wu; James Li; Ming Hu; Yusong Gong; Hong Cheng; Bharathi Laxman; Adaikkalam Vellaichamy; Sunita Shankar; Yong Li; Saravana M Dhanasekaran; Roger Morey; Terrence Barrette; Robert J Lonigro; Scott A Tomlins; Sooryanarayana Varambally; Zhaohui S Qin; Arul M Chinnaiyan
Journal:  Cancer Cell       Date:  2010-05-18       Impact factor: 31.743

2.  Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer.

Authors:  Christopher E Barbieri; Sylvan C Baca; Michael S Lawrence; Francesca Demichelis; Mirjam Blattner; Jean-Philippe Theurillat; Thomas A White; Petar Stojanov; Eliezer Van Allen; Nicolas Stransky; Elizabeth Nickerson; Sung-Suk Chae; Gunther Boysen; Daniel Auclair; Robert C Onofrio; Kyung Park; Naoki Kitabayashi; Theresa Y MacDonald; Karen Sheikh; Terry Vuong; Candace Guiducci; Kristian Cibulskis; Andrey Sivachenko; Scott L Carter; Gordon Saksena; Douglas Voet; Wasay M Hussain; Alex H Ramos; Wendy Winckler; Michelle C Redman; Kristin Ardlie; Ashutosh K Tewari; Juan Miguel Mosquera; Niels Rupp; Peter J Wild; Holger Moch; Colm Morrissey; Peter S Nelson; Philip W Kantoff; Stacey B Gabriel; Todd R Golub; Matthew Meyerson; Eric S Lander; Gad Getz; Mark A Rubin; Levi A Garraway
Journal:  Nat Genet       Date:  2012-05-20       Impact factor: 38.330

Review 3.  Common gene rearrangements in prostate cancer.

Authors:  Mark A Rubin; Christopher A Maher; Arul M Chinnaiyan
Journal:  J Clin Oncol       Date:  2011-08-22       Impact factor: 44.544

4.  Characterization of ERG, AR and PTEN gene status in circulating tumor cells from patients with castration-resistant prostate cancer.

Authors:  Gerhardt Attard; Joost F Swennenhuis; David Olmos; Alison H M Reid; Elaine Vickers; Roger A'Hern; Rianne Levink; Frank Coumans; Joana Moreira; Ruth Riisnaes; Nikhil Babu Oommen; George Hawche; Charles Jameson; Emilda Thompson; Ronald Sipkema; Craig P Carden; Christopher Parker; David Dearnaley; Stan B Kaye; Colin S Cooper; Arturo Molina; Michael E Cox; Leon W M M Terstappen; Johann S de Bono
Journal:  Cancer Res       Date:  2009-04-01       Impact factor: 12.701

5.  ETV1 directs androgen metabolism and confers aggressive prostate cancer in targeted mice and patients.

Authors:  Esther Baena; Zhen Shao; Douglas E Linn; Kimberly Glass; Melanie J Hamblen; Yuko Fujiwara; Jonghwan Kim; Minh Nguyen; Xin Zhang; Frank J Godinho; Roderick T Bronson; Lorelei A Mucci; Massimo Loda; Guo-Cheng Yuan; Stuart H Orkin; Zhe Li
Journal:  Genes Dev       Date:  2013-03-15       Impact factor: 11.361

6.  Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer.

Authors:  Wennuan Liu; Sari Laitinen; Sofia Khan; Mauno Vihinen; Jeanne Kowalski; Guoqiang Yu; Li Chen; Charles M Ewing; Mario A Eisenberger; Michael A Carducci; William G Nelson; Srinivasan Yegnasubramanian; Jun Luo; Yue Wang; Jianfeng Xu; William B Isaacs; Tapio Visakorpi; G Steven Bova
Journal:  Nat Med       Date:  2009-04-12       Impact factor: 53.440

7.  Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer.

Authors:  A H M Reid; G Attard; L Ambroisine; G Fisher; G Kovacs; D Brewer; J Clark; P Flohr; S Edwards; D M Berney; C S Foster; A Fletcher; W L Gerald; H Møller; V E Reuter; P T Scardino; J Cuzick; J S de Bono; C S Cooper
Journal:  Br J Cancer       Date:  2010-01-26       Impact factor: 7.640

8.  Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesis.

Authors:  Jennifer C King; Jin Xu; John Wongvipat; Haley Hieronymus; Brett S Carver; David H Leung; Barry S Taylor; Chris Sander; Robert D Cardiff; Suzana S Couto; William L Gerald; Charles L Sawyers
Journal:  Nat Genet       Date:  2009-04-26       Impact factor: 38.330

9.  Nuclear receptor-induced chromosomal proximity and DNA breaks underlie specific translocations in cancer.

Authors:  Chunru Lin; Liuqing Yang; Bogdan Tanasa; Kasey Hutt; Bong-gun Ju; Kenny Ohgi; Jie Zhang; David W Rose; Xiang-Dong Fu; Christopher K Glass; Michael G Rosenfeld
Journal:  Cell       Date:  2009-12-11       Impact factor: 41.582

10.  ETS factors reprogram the androgen receptor cistrome and prime prostate tumorigenesis in response to PTEN loss.

Authors:  Yu Chen; Ping Chi; Shira Rockowitz; Phillip J Iaquinta; Tambudzai Shamu; Shipra Shukla; Dong Gao; Inna Sirota; Brett S Carver; John Wongvipat; Howard I Scher; Deyou Zheng; Charles L Sawyers
Journal:  Nat Med       Date:  2013-06-30       Impact factor: 53.440
View more
  5 in total

1.  Recurrent prostate cancer genomic alterations predict response to brachytherapy treatment.

Authors:  Jacqueline Fontugne; Daniel Lee; Chiara Cantaloni; Christopher E Barbieri; Orazio Caffo; Esther Hanspeter; Guido Mazzoleni; Paolo Dalla Palma; Mark A Rubin; Giovanni Fellin; Juan Miguel Mosquera; Mattia Barbareschi; Francesca Demichelis
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-02-10       Impact factor: 4.254

2.  Loss of EGR3 is an independent risk factor for metastatic progression in prostate cancer.

Authors:  Seung-Hyun Shin; Iljin Kim; Jae Eun Lee; Mingyu Lee; Jong-Wan Park
Journal:  Oncogene       Date:  2020-08-14       Impact factor: 9.867

Review 3.  Androgen synthesis inhibitors in the treatment of castration-resistant prostate cancer.

Authors:  Mark N Stein; Neal Patel; Alexander Bershadskiy; Alisa Sokoloff; Eric A Singer
Journal:  Asian J Androl       Date:  2014 May-Jun       Impact factor: 3.285

4.  Seminoma and embryonal carcinoma footprints identified by analysis of integrated genome-wide epigenetic and expression profiles of germ cell cancer cell lines.

Authors:  Yvonne G van der Zwan; Martin A Rijlaarsdam; Fernando J Rossello; Amanda J Notini; Suzan de Boer; D Neil Watkins; Ad J M Gillis; Lambert C J Dorssers; Stefan J White; Leendert H J Looijenga
Journal:  PLoS One       Date:  2014-06-02       Impact factor: 3.240

5.  Integrative identification of deregulated miRNA/TF-mediated gene regulatory loops and networks in prostate cancer.

Authors:  Ali Sobhi Afshar; Joseph Xu; John Goutsias
Journal:  PLoS One       Date:  2014-06-26       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.